• Pure Extracts (PULL) commences production of 25 thousand vape cartridges in preparation for retail distribution
  • Pure estimates retail sales revenue for this production run will be approximately $750,000
  • These vape 510 cartridges are produced by a global manufacturer and adhere to the highest North American test standards
  • Pure Extracts features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia
  • Pure Extracts Technologies Corp. (PULL) is in the grey and is trading at C$0.34 at 12:54 pm ET

Pure Extracts Technologies Corp. (PULL) has begun the production of 25,000 vape cartridges for the Canadian retail market.

Demand for Pure Extracts’ Pure Pulls branded 510 Vape cartridges is strong within the provincial markets.

Pure estimates retail sales revenue for this production run will be approximately $750,000.

The cartridges will be filled with a selection of some of Pure’s 30+ proprietary, full-spectrum oil (FSO), formulations including Super Lemon Haze, Grand Daddy Purple, and Girl Scout Cookies/GSK.

These vape 510 cartridges are produced by a global manufacturer and adhere to the highest North American test standards.

These products were specifically chosen for the quality of their component parts, their fit, and finish, and their performance characteristics when paired with Pure Extracts’ oil concentrates.

Pure Extracts CEO, Ben Nikolaevsky, remarked,

“We are excited about preparing to ship our first vape cart orders to the provincial distribution channels.”

“We have created the high-quality FSO vape products that consumers now demand and believe that we will quickly build brand loyalty with both legacy and new entrants in the vape space,” added Nikolaevsky.

Pure Extracts features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia.

Pure Extracts Technologies Corp. (PULL) is in the grey and is trading at C$0.34 at 12:54 pm ET.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.